Immix Biopharma OverviewImmix Biopharma EBIT
EBIT (Earnings Before Interest and Taxes) analysis for IMMX.
Quarterly EBIT
-$10.80M
↓ 130.71% YoY
As of Mar 31, 2026
Annual EBIT (TTM)
-$35.89M
↓ 64.72% YoY
Trailing 12 months ending Mar 31, 2026
Immix Biopharma OverviewEBIT (Earnings Before Interest and Taxes) analysis for IMMX.
As of Mar 31, 2026
Trailing 12 months ending Mar 31, 2026